2-[4-[5-(1H-indazol-5-ylamino)-1-(2-methoxyethyl)-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide
C24H29N7O4 — CID 139365755
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[5-(1H-indazol-5-ylamino)-1-(2-methoxyethyl)-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide
2-[4-[5-(1H-indazol-5-ylamino)-1-(2-methoxyethyl)-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide (PubChem CID 139365755) has the molecular formula C24H29N7O4 and a molecular weight of 479.54 g/mol. Its IUPAC name is 2-[4-[5-(1H-indazol-5-ylamino)-1-(2-methoxyethyl)-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide.
Molecular Properties
| Compound Name | 2-[4-[5-(1H-indazol-5-ylamino)-1-(2-methoxyethyl)-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide |
|---|---|
| PubChem CID | 139365755 |
| Molecular Formula | C24H29N7O4 |
| Molecular Weight | 479.54 g/mol |
| Exact Mass | 479.23 |
| IUPAC Name | 2-[4-[5-(1H-indazol-5-ylamino)-1-(2-methoxyethyl)-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide |
| SMILES | COCCn1nc(-c2ccc(OCC(=O)NC(C)C)c(OC)c2)nc1Nc1ccc2[nH]ncc2c1 |
| InChI | InChI=1S/C24H29N7O4/c1-15(2)26-22(32)14-35-20-8-5-16(12-21(20)34-4)23-28-24(31(30-23)9-10-33-3)27-18-6-7-19-17(11-18)13-25-29-19/h5-8,11-13,15H,9-10,14H2,1-4H3,(H,25,29)(H,26,32)(H,27,28,30) |
| InChIKey | MZJKIIHIUCWKIZ-UHFFFAOYSA-N |
| XLogP | 3.12 |
| TPSA | 128.21 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 479.54 |
| LogP ≤ 5 | 3.12 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139365755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.